Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics.  He earned his medical degree at Albert Einstein College of Medicine and completed an internship in internal medicine at Mount Sinai St. Luke's and Mount Sinai West Hospital and a residency in radiation oncology at Montefiore Medical Center, where he was chief resident in the Department of Radiation Oncology.  Dr. Kabarriti is the recipient of the prestigious American Society of Clinical Oncology and Conquer Cancer Foundation Young Investigator Award, Empire Clinical Research Investigator Program Fellowship and AIDS Malignancy Consortium fellowship Award.  He is also funded by the NIH K12 Paul Calabresi Career Development Award for Clinical Oncology.  His research has been selected for oral presentations at national and international meetings including the annual meetings of the American Society for Radiation Oncology, European Society for Radiotherapy, and the European ORL-HNS Congress. Dr. Kabarriti is author and co-author of over 40 articles published in peer-reviewed journals including the Journal of Clinical Oncology, International Journal of Radiation Oncology, Biology, and Physics, Oral Oncology and Head and Neck. His research focus is on optimizing radiation therapy for head and neck and gastrointestinal cancers and combining radiation therapy with novel therapeutics and immunotherapy to improve outcomes for these patients.  He is the principal investigator of multiple clinical trials including investigator-initiated clinical trials as well as the local PI on cooperative and international studies.   

Selected Publications:

1.  Kabarriti, R. Ohri, N. Hannan, R. Tishbi, N. Baliga, S. McGovern, KP. Mourad, WF. Ghavamian, R. Kalnicki, S. Guha, C. Garg, MK. PSA Decline During Salvage Radiation Therapy Following Prostatectomy Is Associated With Reduced Biochemical Failure.  Practical Radiation Oncology, 2014 Feb 21.  

2.  Kabarriti, R. Guha, C. Hedgehog Signaling and Radiation Induced Liver Injury: A Delicate Balance.  Hepatology International, 2014 Jul;8(3):316-20.

3.  Kabarriti R, Mark D, Fox J, Kalnicki S, Garg MK. Proton therapy for the treatment of pediatric head and neck cancers: A review. Int J Pediatr Otorhinolaryngol. 2016 Jan;79(12)

4.  Kabarriti R, Quinn TJ, Ewart MR, Mehta KJ, Lomita C, Geller DS, Kalnicki S, Fox JL. Neoadjuvant radiation therapy for the management of myoepithelial carcinoma of the upper extremity. Int J Cancer. 2018 Feb 15;142(4), PMCID: PMC6200873

5.  Kabarriti R, Bontempo A, Romano M, McGovern KP, Asaro A, Viswanathan S, Kalnicki S, Garg MK. The Impact of Dietary Regimen Compliance on Outcomes for HNSCC Patients Treated with Radiation Therapy. Supportive Care in Cancer, 2018 Sep;26(9):3307-3313; PMID: 29671062

6.  Ohri N, Kabarriti R, Kaubisch A, Guha C. RFA versus SBRT for HCC: Caution when Interpreting Observational Data; Journal of Clinical Oncology, 2018 Aug 20;36(24):2558; PMID: 29945527

7.  Baliga S*, Kabarriti R*, Jiang J, Mehta V, Guha C, Kalnicki S, Smith RV, Garg, MK. Utilization of Transoral Robotic Surgery (TORS) in Patients with Oropharyngeal Squamous Cell Carcinoma and its impact on Survival and use of Chemotherapy.  Oral Oncology, 2018 Nov;86:75-80; PMID: 30409323   *co-first author

8.  Brodin NP, Kabarriti R, Pankuch M, Schechter CB, Gondi V, Kalnicki S, Guha C, Garg MK, Tomé WA.  A Quantitative Clinical Decision-support Strategy Identifying Which Oropharyngeal Head and Neck Cancer Patients may Benefit the Most from Proton Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Nov 26.  PMID: 30496877

9.  Barahman M, Asp P, Roy-Chowdhury N, Kinkhabwala M, Roy-Chowdhury J, Kabarriti R, Guha C.  Hepatocyte Transplantation: Quo Vadis? Int J Radiat Oncol Biol Phys. 2018 Nov 29.  PMID: 30503786

10.  Kabarriti R, Brodin NP, Lundgren G, Ohri N, Tomé, WA, Kalnicki S, Garg MK. Early Response Assessment on Mid-Treatment CT Predicts Loco-Regional Recurrence in Oropharyngeal Cancer Patients Treated with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1036-1045; PMID: 29779936

11. Kabarriti R, Baliga S, Ohri N, Guha C, Kalnicki S, Garg, MK. Radiotherapy for Patients With Newly Diagnosed Metastatic Head and Neck Squamous Cell Carcinoma.  Head and Neck, 2018 Dec 16.  PMID: 30556318

12.  Barahman M, Zhang W, Yaffe Harris H, Aiyer A, Kabarriti R, Kinkhabwala M, Roy-Chowdhury N, Beck AP, Scanlan TS, Roy-Chowdhury J, Asp P, Guha C. Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.  J Hepatol. 2019 Jan 14.  PMID: 30654068

13.  Kabarriti R, Brodin NP, Ahmed S, Vogelius I, Guha C, Kalnicki S, Tomé WA, Garg MK.  Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging.  Cureus. 2019 Jan 8;11(1):e3856; PMID: 30899607

14.  Jiang JM, Ohri N, Tang J, Moadel R, Cynamon J, Kaubisch A, Kinkhabwala M, Garg MK, Guha C, Kabarriti R.  Centers with More Therapeutic Modalities are Associated with Improved Outcomes for Patients with Hepatocellular Carcinoma.  Journal of Gastrointestinal Oncology, 2019 Jun;10(3):546-553. PMID: 31183206

15.  Kabarriti R, Brodin NP, Ohri N, Narang R, Huang R, Chuy JW, Rajdev LN, Kalnicki S, Guha C, Garg MK.  Human Papillomavirus, Radiation Dose and Survival of Patients with Anal Cancer. Acta Oncolgica, 2019 Jul 8:1-7, PMID: 31282249

16.  Zhang Y, Brodin NP, Ohri N, Thibaud S, Kaubisch A, Kinkhabwala M, Garg MK, Guha C, Kabarriti R.  Association Between Neutrophil-lymphocyte Ratio, Socioeconomic Status, and Ethnic Minority with Treatment Outcome in Hepatocellular Carcinoma. Hepatology International, 2019 Sep;13(5):609-617, PMID: 31372942

17.  Zhu S, Brodin NP, English K, Ohri N, Chuy JW, Rajdev LN, Narang R, Kalnicki S, Guha C, Garg MK, Kabarriti R.  Comparing Outcomes Following Total Neoadjuvant Therapy and Following Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer. EClinicalMedicine, in Press